Fortuna Helix

Fortuna Helix is a genomic analysis and disease risk prediction company specializing in polygenic risk score (PRS) modeling for proactive disease prevention and personalized health management. The company provides comprehensive DNA analysis to assess individual susceptibility to 37 major diseases and BMI obesity risk, leveraging advanced statistical modeling and genetic data analysis techniques. Fortuna Helix delivers actionable genomic insights to both healthcare providers and patients, enabling early intervention and informed lifestyle modifications. Their product portfolio includes Disease Prediction analysis, Obesity Prediction and Prevention modules, Height Prediction, and Genetic Health Indicators. The platform functions as a clinical decision-support tool, translating complex genetic data into personalized preventive guidance. Fortuna Helix serves both B2C patients seeking proactive health management and B2B healthcare providers integrating genomic risk assessment into preventive care workflows. The company operates from Irvine, California, and focuses on advancing precision medicine through accessible genomic insights that empower individuals to make informed decisions about disease prevention and self-care based on their unique genetic profiles.